Abstract:
Nanogen, Inc. announced today that it was issued U.S. Patent No. 6,682,936, "Addressable Biologic Electrode Array," by the U.S. Patent and Trademark Office. The '936 patent relates to electrode-based array devices and methods of operation in which individual electrodes contained within the array can be selectively addressed or manipulated. The technology enables high-density electrode arrays to be produced and has applications for the hybridization as well as combinatorial synthesis and self-assembly of biological molecules, such as nucleic acids and peptides.